| JUN |
K562 (myelogenous leukemia) |
30 m of Interferon alpha (Snyder) |
Permissive
Robust
|
Homo sapiens |
ENCSR000EGH
|
MA0488.1
...
|
| JUN |
A549 (lung carcinoma) |
100nM dexamethasone (CHEBI:41879) for 25 minute |
Permissive
|
Homo sapiens |
ENCSR604CKQ
|
MA0099.3
...
|
| JUN |
A549 (lung carcinoma) |
100nM dexamethasone (CHEBI:41879) for 10 minute |
Permissive
Robust
|
Homo sapiens |
ENCSR022WVP
|
MA0099.3
...
|
| JUN |
A549 (lung carcinoma) |
100nM dexamethasone (CHEBI:41879) for 15 minute |
Permissive
Robust
|
Homo sapiens |
ENCSR716SJK
|
MA0099.3
...
|
| JUN |
A549 (lung carcinoma) |
100nM dexamethasone (CHEBI:41879) for 5 minute |
Permissive
Robust
|
Homo sapiens |
ENCSR110UPH
|
MA0099.3
...
|
| JUN |
MCF7 (Invasive ductal breast carcinoma) |
E2 |
Permissive
|
Homo sapiens |
GSE26831
...
|
MA0099.3
...
|
| JUN |
BMDM (bone marrow-derived macrophages) |
LPS-stimulated |
Permissive
Robust
|
Mus musculus |
GSE31796
...
|
MA0099.3
...
|
| JUN |
BMDM (bone marrow-derived macrophages) |
Dexamethasone treated, LPS-stimulated |
Permissive
Robust
|
Mus musculus |
GSE31796
...
|
MA0099.3
...
|
| JUN |
CD4+ T-cells |
IL21 |
Permissive
Robust
|
Mus musculus |
GSE39756
...
|
MA0099.3
...
|
| JUN |
CD4+ T-cells |
IL21, IRF4KO |
Permissive
Robust
|
Mus musculus |
GSE39756
...
|
MA0099.3
...
|
| JUN |
OG2 transgenetic mouse embryonic stem cells |
KSM; Doxycycline |
Permissive
Robust
|
Mus musculus |
GSE50776
...
|
MA0099.3
...
|
| JUN |
OG2 transgenetic mouse embryonic fibroblasts |
KSM; Doxycycline; c-Jun (dominant negative) |
Permissive
|
Mus musculus |
GSE50776
...
|
MA0099.3
...
|
| JUN |
MDA-MB-231 (breast adenocarcinoma) |
dexametasone |
Permissive
Robust
|
Homo sapiens |
GSE56022
...
|
MA0099.3
...
|
| JUN |
MDA-MB-231 (breast adenocarcinoma) |
compaund A |
Permissive
Robust
|
Homo sapiens |
GSE56022
...
|
MA0099.3
...
|
| JUN |
Flk1+ hemangioblasts |
0d |
Permissive
Robust
|
Mus musculus |
GSE79320
...
|
MA0099.3
...
|
| JUN |
Flk1+ hemangioblasts |
0d |
Permissive
Robust
|
Mus musculus |
GSE79320
...
|
MA0099.3
...
|
| JUN |
Flk1+ hemangioblasts |
1d |
Permissive
Robust
|
Mus musculus |
GSE79320
...
|
MA0099.3
...
|
| JUN |
liver |
sham surgery, 14 days after surgery |
Permissive
|
Rattus norvegicus |
GSE87730
...
|
MA0099.3
...
|
| JUN |
liver |
ligated bile duct, 14 days after surgery |
Permissive
Robust
|
Rattus norvegicus |
GSE87730
...
|
MA0099.3
...
|
| JUN |
liver |
sham surgery, 5 days after surgery |
Permissive
|
Rattus norvegicus |
GSE87730
...
|
MA0099.3
...
|
| JUN |
liver |
ligated bile duct, 5 days after surgery |
Permissive
Robust
|
Rattus norvegicus |
GSE87730
...
|
MA0099.3
...
|
| JUN |
liver |
sham surgery, 1 day after surgery |
Permissive
|
Rattus norvegicus |
GSE87730
...
|
MA0099.3
...
|
| JUN |
liver |
ligated bile duct, 1 day after surgery |
Permissive
Robust
|
Rattus norvegicus |
GSE87730
...
|
MA0099.3
...
|
| JUN |
HAEC (human aortic endothelial cells) |
TNFa, 4h |
Permissive
Robust
|
Homo sapiens |
GSE89970
...
|
MA0099.3
...
|
| JUN |
HAEC (human aortic endothelial cells) |
IL1b, 4h |
Permissive
Robust
|
Homo sapiens |
GSE89970
...
|
MA0099.3
...
|
| JUN |
HAEC (human aortic endothelial cells) |
oxpapc, 4h |
Permissive
Robust
|
Homo sapiens |
GSE89970
...
|
MA0099.3
...
|
| JUN |
HAEC (human aortic endothelial cells) |
control, 4h |
Permissive
Robust
|
Homo sapiens |
GSE89970
...
|
MA0099.3
...
|
| JUN |
A549 (lung carcinoma) |
100nM dexamethasone (CHEBI:41879) for 12 hour |
Permissive
Robust
|
Homo sapiens |
ENCSR664ZHF
|
MA0099.3
...
|
| JUN |
A549 (lung carcinoma) |
100nM dexamethasone (CHEBI:41879) for 6 hour |
Permissive
Robust
|
Homo sapiens |
ENCSR612GKD
|
MA0099.3
...
|
| JUN |
A549 (lung carcinoma) |
100nM dexamethasone (CHEBI:41879) for 30 minute |
Permissive
Robust
|
Homo sapiens |
ENCSR761RDU
|
MA0099.3
...
|
| JUN |
A549 (lung carcinoma) |
100nM dexamethasone (CHEBI:41879) for 8 hour |
Permissive
|
Homo sapiens |
ENCSR783THJ
|
MA0099.3
...
|
| JUN |
A549 (lung carcinoma) |
1 h with 100 nM Dexamethasone (Myers) |
Permissive
|
Homo sapiens |
ENCSR991VVW
|
MA0099.3
...
|
| JUN |
A549 (lung carcinoma) |
100nM dexamethasone (CHEBI:41879) for 10 hour |
Permissive
Robust
|
Homo sapiens |
ENCSR090RGB
|
MA0099.3
...
|
| JUN |
A549 (lung carcinoma) |
100nM dexamethasone (CHEBI:41879) for 7 hour |
Permissive
|
Homo sapiens |
ENCSR991RJM
|
MA0099.3
...
|
| JUN |
A549 (lung carcinoma) |
100nM dexamethasone (CHEBI:41879) for 3 hour |
Permissive
|
Homo sapiens |
ENCSR489DIG
|
MA0099.3
...
|
| JUN |
A549 (lung carcinoma) |
100nM dexamethasone (CHEBI:41879) for 2 hour |
Permissive
|
Homo sapiens |
ENCSR793HZD
|
MA0099.3
...
|
| JUN |
A549 (lung carcinoma) |
100nM dexamethasone (CHEBI:41879) for 4 hour |
Permissive
Robust
|
Homo sapiens |
ENCSR708DGM
|
MA0099.3
...
|
| JUN |
A549 (lung carcinoma) |
100nM dexamethasone (CHEBI:41879) for 5 hour |
Permissive
|
Homo sapiens |
ENCSR504LBE
|
MA0099.3
...
|
| JUN |
MCF7 (Invasive ductal breast carcinoma) |
Source: cJun - Tet cells; CellType: ERalpha-positive breast cancer cells; Treatment: ethanol 1hr; |
Permissive
Robust
|
Homo sapiens |
GSE102410
...
|
MA0099.3
...
|
| JUN |
MCF7 (Invasive ductal breast carcinoma) |
Source: cJun - Tet cells; CellType: ERalpha-positive breast cancer cells; Treatment: 17beta estradiol 10nM for 1hr; |
Permissive
Robust
|
Homo sapiens |
GSE102410
...
|
MA0099.3
...
|
| JUN |
MCF7 (Invasive ductal breast carcinoma) |
Source: cJun - Tet cells; CellType: ERalpha-positive breast cancer cells; Treatment: tamoxifen 1μM for 1hr; |
Permissive
Robust
|
Homo sapiens |
GSE102410
...
|
MA0099.3
...
|
| JUN |
HUVEC-C (HUVEC, umbilical vein endothelial cells) |
Treatment: agent VEGF, timepoint 0 Passage: P3-6 |
Permissive
Robust
|
Homo sapiens |
GSE109625
...
|
MA0099.3
...
|
| JUN |
HUVEC-C (HUVEC, umbilical vein endothelial cells) |
Treatment: agent VEGF, timepoint 1 Passage: P3-6 |
Permissive
Robust
|
Homo sapiens |
GSE109625
...
|
MA0099.3
...
|
| JUN |
HUVEC-C (HUVEC, umbilical vein endothelial cells) |
Treatment: agent VEGF, timepoint 4 Passage: P3-6 |
Permissive
Robust
|
Homo sapiens |
GSE109625
...
|
MA0099.3
...
|
| JUN |
HUVEC-C (HUVEC, umbilical vein endothelial cells) |
Treatment: agent VEGF, timepoint 012Passage: P3-6 |
Permissive
Robust
|
Homo sapiens |
GSE109625
...
|
MA0099.3
...
|
| JUN |
MCF10A-ER-Src |
Genotype: non-transformed |
Permissive
Robust
|
Homo sapiens |
GSE115597
...
|
MA0099.3
...
|
| JUN |
MCF10A-ER-Src |
Genotype: transformed |
Permissive
Robust
|
Homo sapiens |
GSE115597
...
|
MA0099.3
...
|
| JUN |
DRG (Dorsal Root Ganglia) |
Treatment: bilateral sciatic nerve crush Age: 6-8 weeks old Strain: C57BL/6 |
Permissive
|
Mus musculus |
GSE105442
...
|
MA0099.3
...
|
| JUN |
DRG (Dorsal Root Ganglia) |
Treatment: bilateral sciatic nerve crush Age: 6-8 weeks old Strain: C57BL/6 |
Permissive
|
Mus musculus |
GSE105442
...
|
MA0099.3
...
|
| JUN |
DRG (Dorsal Root Ganglia) |
Treatment: bilateral sciatic nerve crush Age: 6-8 weeks old Strain: C57BL/6 |
Permissive
|
Mus musculus |
GSE105442
...
|
MA0099.3
...
|
| JUN |
DRG (Dorsal Root Ganglia) |
Treatment: sham Age: 6-8 weeks old Strain: C57BL/6 |
Permissive
|
Mus musculus |
GSE105442
...
|
MA0099.3
...
|
| JUN |
DRG (Dorsal Root Ganglia) |
Treatment: sham Age: 6-8 weeks old Strain: C57BL/6 |
Permissive
|
Mus musculus |
GSE105442
...
|
MA0099.3
...
|
| JUN |
DRG (Dorsal Root Ganglia) |
Treatment: sham Age: 6-8 weeks old Strain: C57BL/6 |
Permissive
|
Mus musculus |
GSE105442
...
|
MA0099.3
...
|
| JUN |
BMDM (bone marrow-derived macrophages) |
KLA 1h; SPRET/EiJ strain |
Permissive
Robust
|
Mus musculus |
GSE109965
...
|
MA0099.3
...
|
| JUN |
BMDM (bone marrow-derived macrophages) |
SPRET/EiJ strain |
Permissive
Robust
|
Mus musculus |
GSE109965
...
|
MA0099.3
...
|
| JUN |
BMDM (bone marrow-derived macrophages) |
KLA 1h; PWK/PhJ strain |
Permissive
Robust
|
Mus musculus |
GSE109965
...
|
MA0099.3
...
|
| JUN |
BMDM (bone marrow-derived macrophages) |
PWK/PhJ strain |
Permissive
Robust
|
Mus musculus |
GSE109965
...
|
MA0099.3
...
|
| JUN |
BMDM (bone marrow-derived macrophages) |
NOD/ShiLtJ strain |
Permissive
Robust
|
Mus musculus |
GSE109965
...
|
MA0099.3
...
|
| JUN |
BMDM (bone marrow-derived macrophages) |
KLA 1h; NOD/ShiLtJ strain |
Permissive
Robust
|
Mus musculus |
GSE109965
...
|
MA0099.3
...
|
| JUN |
BMDM (bone marrow-derived macrophages) |
KLA 1h; C57BL/6J strain |
Permissive
Robust
|
Mus musculus |
GSE109965
...
|
MA0099.3
...
|
| JUN |
BMDM (bone marrow-derived macrophages) |
C57BL/6J strain |
Permissive
Robust
|
Mus musculus |
GSE109965
...
|
MA0099.3
...
|
| JUN |
BMDM (bone marrow-derived macrophages) |
BALB/cJ |
Permissive
Robust
|
Mus musculus |
GSE109965
...
|
MA0099.3
...
|
| JUN |
BMDM (bone marrow-derived macrophages) |
KLA 1h; BALB/cJ |
Permissive
Robust
|
Mus musculus |
GSE109965
...
|
MA0099.3
...
|
| JUN |
primary hepatocytes |
Strain: C57BL/6 Source: primary mouse hepatocytes Treatment: IL-1b (10ng/ml) for 2 hr |
Permissive
Robust
|
Mus musculus |
GSE96767
...
|
MA0099.3
...
|
| JUN |
definitive endoderm from HUES8 |
Genotype: SOX17-GFP knockout; Treatment: DMSO; |
Permissive
Robust
|
Homo sapiens |
GSE109524
...
|
MA0099.3
...
|
| JUN |
HUES8 (Embryonic stem cell, blastocyst stage) |
Genotype: SOX17-GFP knockout; |
Permissive
|
Homo sapiens |
GSE109524
...
|
MA0099.3
...
|
| JUN |
definitive endoderm from HUES8 |
Genotype: SOX17-GFP knockout; Treatment: DMSO; |
Permissive
Robust
|
Homo sapiens |
GSE109524
...
|
MA0099.3
...
|
| JUN |
HUES8 (Embryonic stem cell, blastocyst stage) |
Genotype: SOX17-GFP knockout; |
Permissive
|
Homo sapiens |
GSE109524
...
|
MA0099.3
...
|
| JUN |
MDA-MB-231-1833 (breast cancer cells, bone-tropic metastatic line) |
Genotype: p27 knockdown; Source: MDA-MB-231-1833shp27; |
Permissive
|
Homo sapiens |
GSE112444
...
|
MA0099.3
...
|
| JUN |
MDA-MB-231-1833 (breast cancer cells, bone-tropic metastatic line) |
Genotype: p27 knockdown; Source: MDA-MB-231-1833shp27; |
Permissive
|
Homo sapiens |
GSE112444
...
|
MA0099.3
...
|
| JUN |
Kasumi-1 (acute myeloblastic leukemia) |
Genotype: control (scrambled shRNA); |
Permissive
Robust
|
Homo sapiens |
GSE117105
...
|
MA0099.3
...
|
| JUN |
Kasumi-1 (acute myeloblastic leukemia) |
Genotype: RUNX1/ETO knockdown; |
Permissive
Robust
|
Homo sapiens |
GSE117105
...
|
MA0099.3
...
|
| JUN |
bone marrow-derived macrophages |
Sex: male; Strain:C57Bl6; Treatment: PBS (Veh); Source: thioglycollate elicited macrophage cells; Genotype: PPARg knockout; |
Permissive
Robust
|
Mus musculus |
GSE111854
...
|
MA0099.3
...
|
| JUN |
bone marrow-derived macrophages |
Sex: male; Strain:C57Bl/6EiJ; Treatment: KLA for 1 hr; Source: thioglycollate elicited macrophage cells; |
Permissive
Robust
|
Mus musculus |
GSE111854
...
|
MA0099.3
...
|
| JUN |
bone marrow-derived macrophages |
Sex: male; Strain:C57Bl/6EiJ; Treatment: PBS (Veh); Source: thioglycollate elicited macrophage cells; |
Permissive
Robust
|
Mus musculus |
GSE111854
...
|
MA0099.3
...
|
| JUN |
bone marrow-derived macrophages |
Sex: male; Strain:Balb/cJ; Treatment: KLA for 1 hr; Source: thioglycollate elicited macrophage cells; |
Permissive
Robust
|
Mus musculus |
GSE111854
...
|
MA0099.3
...
|
| JUN |
bone marrow-derived macrophages |
Sex: male; Strain:Balb/cJ; Treatment: PBS (Veh); Source: thioglycollate elicited macrophage cells; |
Permissive
Robust
|
Mus musculus |
GSE111854
...
|
MA0099.3
...
|
| JUN |
WA01 (H1, human embryonic stem cells) |
|
Permissive
Robust
|
Homo sapiens |
ENCSR000ECA
|
MA0488.1
...
|
| JUN |
HeLa S3 (cervical adenocarcinoma) |
|
Permissive
Robust
|
Homo sapiens |
ENCSR000EDG
|
MA0488.1
...
|
| JUN |
HepG2 (hepatoblastoma) |
|
Permissive
Robust
|
Homo sapiens |
ENCSR000EEK
|
MA0488.1
...
|
| JUN |
HUVEC-C (HUVEC, umbilical vein endothelial cells) |
|
Permissive
Robust
|
Homo sapiens |
ENCSR000EFA
|
MA0488.1
...
|
| JUN |
K562 (myelogenous leukemia) |
|
Permissive
Robust
|
Homo sapiens |
ENCSR000EFS
|
MA0488.1
...
|
| JUN |
K562 (myelogenous leukemia) |
|
Permissive
Robust
|
Homo sapiens |
ENCSR000FAH
|
MA0488.1
...
|
| JUN |
MCF7 (Invasive ductal breast carcinoma) |
|
Permissive
Robust
|
Homo sapiens |
ENCSR176EXN
|
MA0488.1
...
|
| JUN |
A549 (lung carcinoma) |
|
Permissive
Robust
|
Homo sapiens |
ENCSR996DUT
|
MA0488.1
...
|
| JUN |
A549 (lung carcinoma) |
|
Permissive
Robust
|
Homo sapiens |
ENCSR192PBJ
|
MA0099.3
...
|
| JUN |
K562 (myelogenous leukemia) |
|
Permissive
Robust
|
Homo sapiens |
GSE19545
...
|
MA0099.3
...
|
| JUN |
MCF7 (Invasive ductal breast carcinoma) |
|
Permissive
|
Homo sapiens |
GSE26831
...
|
MA0099.3
...
|
| JUN |
CH12.LX (Mouse lymphoma) |
|
Permissive
Robust
|
Mus musculus |
ENCSR000ERO
...
|
MA0099.3
...
|
| JUN |
3T3-L1 (embryonic fibroblasts) |
|
Permissive
Robust
|
Mus musculus |
GSE33821
...
|
MA0099.3
...
|
| JUN |
C2C12 (myoblasts) |
|
Permissive
Robust
|
Mus musculus |
GSE37525
...
|
MA0099.3
...
|
| JUN |
CD4+ T-cells |
|
Permissive
Robust
|
Mus musculus |
GSE39756
...
|
MA0099.3
...
|
| JUN |
Th17-cells |
|
Permissive
Robust
|
Mus musculus |
GSE39756
...
|
MA0099.3
...
|
| JUN |
CD8+ T-cells |
|
Permissive
Robust
|
Mus musculus |
GSE54191
...
|
MA0099.3
...
|
| JUN |
3T3-L1 (embryonic fibroblasts) |
|
Permissive
Robust
|
Mus musculus |
GSE56872
...
|
MA0099.3
...
|
| JUN |
MDA-MB-231 (breast adenocarcinoma) |
|
Permissive
Robust
|
Homo sapiens |
GSE56022
...
|
MA0099.3
...
|
| JUN |
myoblasts |
|
Permissive
Robust
|
Mus musculus |
GSE56077
...
|
MA0099.3
...
|
| JUN |
chondrocytes |
|
Permissive
Robust
|
Mus musculus |
GSE73372
...
|
MA0099.3
...
|
| JUN |
intestine |
|
Permissive
|
Mus musculus |
GSE74992
...
|
MA0099.3
...
|
| JUN |
Calu-3 (lung adenocarcinoma) |
|
Permissive
Robust
|
Homo sapiens |
GSE85401
...
|
MA0099.3
...
|
| JUN |
RCC 7860 (Renal cell carcinoma) |
|
Permissive
Robust
|
Homo sapiens |
GSE86092
...
|
MA0099.3
...
|
| JUN |
HCC827 (lung adenocarcinoma) |
|
Permissive
|
Homo sapiens |
GSE95590
...
|
MA0099.3
...
|
| JUN |
A549 (lung carcinoma) |
|
Permissive
Robust
|
Homo sapiens |
ENCSR048CVK
|
MA0099.3
...
|
| JUN |
MDA-MB-231 (breast adenocarcinoma) |
|
Permissive
Robust
|
Homo sapiens |
GSE112444
...
|
MA0099.3
...
|
| JUN |
MDA-MB-231 (breast adenocarcinoma) |
|
Permissive
|
Homo sapiens |
GSE112444
...
|
MA0099.3
...
|
| JUN |
MDA-MB-231p27CK-DD (breast cancer cells, phosphimimetic p27 cell line) |
|
Permissive
Robust
|
Homo sapiens |
GSE112444
...
|
MA0099.3
...
|
| JUN |
MDA-MB-231p27CK-DD (breast cancer cells, phosphimimetic p27 cell line) |
|
Permissive
|
Homo sapiens |
GSE112444
...
|
MA0099.3
...
|
| JUN |
MDA-MB-231-1833 (breast cancer cells, bone-tropic metastatic line) |
|
Permissive
|
Homo sapiens |
GSE112444
...
|
MA0099.3
...
|
| JUN |
MDA-MB-231-1833 (breast cancer cells, bone-tropic metastatic line) |
|
Permissive
|
Homo sapiens |
GSE112444
...
|
MA0099.3
...
|
| JUN |
BT-549 (breast invasive ductal carcinoma) |
|
Permissive
Robust
|
Homo sapiens |
GSE46166
|
MA0488.1
...
|
| JUN |
MDA-MB-231 (breast adenocarcinoma) |
|
Permissive
Robust
|
Homo sapiens |
GSE66081
|
MA0488.1
...
|
| JUN |
BT-549 (breast invasive ductal carcinoma) |
TNF |
Permissive
Robust
|
Homo sapiens |
GSE71976
|
MA0488.1
...
|
| JUN |
BT-549 (breast invasive ductal carcinoma) |
|
Permissive
Robust
|
Homo sapiens |
GSE71976
|
MA0488.1
...
|
